Pharma Journalist -

Standardizing and personalizing insulin therapy management for hospitalized patients is a goal Piedmont Healthcare is poised to achieve through expanded use of Glytec’s eGlycemic…
Read More...

Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, announced today $16…
Read More...

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, announced the promotion of…
Read More...

Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused…
Read More...

SMi Group reports: With updates on the recent developments in the industry, and the ever-increased net worth of the medical devices market within the US especially, SMi's Pre-Filled…
Read More...

SMi Group reports: The chronic pain epidemic today affects thousands of patients worldwide. It is now a point of concern for the pharmaceutical industry, for the healthcare industry and…
Read More...

SMi are delighted to have our Chairman, Speaker and Workshop Host, Justin Mason-Home, Director, HPAPI Project Services Limited, onto the speaker panel for HPAPI 2018!…
Read More...

The launch of Injectable Drug Delivery will take place on the 16th - 17th May 2018, in London, UK. Hear from Sanofi as they will be presenting: Advancements of Fill & Finish…
Read More...

SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945). Since that warning, measures have been taken in acknowledgement of the threat of…
Read More...

Sartorius Stedim Biotech (SSB) announced the launch of the ambr 250 high throughput (ht) perfusion, a new automated parallel bioreactor system. It has been specially designed for rapid…
Read More...